| 2025 |
Costin, I. C., & Marcu, L. G. (2025). Impact of immobilization system angle, body mass index and breast size on breast radiotherapy accuracy using EPID-only setup. Heliyon, 11(3), 1-15. DOI Scopus1 Europe PMC1 |
| 2025 |
Bezak, E., Sharrad, K. J., Marcu, L. G., Stoeva, M., Lhotska, L., Barabino, G., . . . Frize, M. (2025). A gender breakdown of unexpected benefits generated by work from home in STEM fields − a qualitative analysis of the WiMPBME Task Group survey. Physica Medica, 130, 1-5. DOI |
| 2025 |
Marcu, L. G., Marcu, D. C., Costin, I. C., Zahu, R., & Straciuc, O. (2025). From immunohistochemistry to machine learning-based patient stratification by tumour proliferation characteristics in head and neck cancer. Critical Reviews in Oncology Hematology, 216, 10 pages. DOI |
| 2025 |
Marcu, L. G., & Marcu, D. C. (2025). Examining the role of AI in cancer imaging through the lens of clinical studies. Health And Technology, online(6), 1-10. DOI Scopus1 WoS1 |
| 2025 |
Costin, I. C., Marcu, L. G., Marcu, D. C., Zahu, R., & Straciuc, O. (2025). Is the use of machine learning in head and neck cancer radiotherapy supported by clinical trials?. Physica Medica, 136(105036), 17 pages. DOI |
| 2025 |
Coc, F. L., & Marcu, L. G. (2025). From CBCT to MR-Linac in image-guided prostate cancer radiotherapy towards treatment personalization. Current Oncology, 32(6, article no. 291), 1-20. DOI |
| 2025 |
Gazsi, I., & Marcu, L. G. (2025). The impact of pre-treatment image guidance on tumor and normal tissue dosimetry during VMAT for cervical cancer. Romanian Journal of Physics, 70(1-2, article no. 701), 1-17. DOI |
| 2025 |
Gazsi, I., & Marcu, L. G. (2025). Systematic review of SBRT boost for cervical cancer patients who cannot benefit from brachytherapy. Current Oncology, 32(3, article no. 170), 1-19. DOI Scopus2 WoS2 Europe PMC1 |
| 2025 |
Gazsi, I., & Marcu, L. G. (2025). Comparative dosimetric assessment of combined treatment modalities in cervical cancer radiotherapy for optimal organ protection. Radiation And Environmental Biophysics, 64(2), 291-302. DOI |
| 2025 |
Catona, G. M., & Marcu, L. G. (2025). Qualitative and quantitative evaluation of the role of CBCT in rectal cancer radiotherapy. Radiologia Medica, 130(2), 150-160. DOI Scopus5 WoS4 Europe PMC3 |
| 2024 |
Costin, I. C., & Marcu, L. G. (2024). Patient and treatment-related factors that influence dose to heart and heart substructures in left-sided breast cancer radiotherapy. Physica Medica, 128(104851), 1-20. DOI Scopus1 WoS1 Europe PMC1 |
| 2024 |
Costin, I. C., Cinezan, C., & Marcu, L. G. (2024). Cardio-oncology concerns in radiotherapy: Heart and cardiac substructure toxicities from modern delivery techniques. Critical Reviews in Oncology Hematology, 204(104538), 19 pages. DOI Scopus5 WoS4 Europe PMC4 |
| 2024 |
Costin, I. C., & Marcu, L. G. (2024). Correlations between patient-specific parameters and dosimetric indices for personalized breast cancer radiotherapy. Scientific Reports, 14(1, article no. 26141), 1-19. DOI |
| 2024 |
Marcu, L. G., & Marcu, D. C. (2024). Pharmacogenomics and Big Data in medical oncology: developments and challenges. Therapeutic Advances in Medical Oncology, 16, 1-18. DOI Scopus5 WoS6 Europe PMC3 |
| 2024 |
Ghemiș, D. M., & Marcu, L. G. (2024). RTOG 0915-compliant patient specific QA for lung stereotactic body radiotherapy using the new PTW 1600SRS detector array. Physica Medica, 127(104822), 1-8. DOI |
| 2024 |
Buciuman, N., Dasu, A., & Marcu, L. G. (2024). Dosimetric evaluation of intensity modulated photon versus proton reirradiation of head and neck cancer. Physica Medica, 123, 1-10. DOI |
| 2024 |
Costin, I. C., & Marcu, L. G. (2024). Affinity of PET-MRI tracers for hypoxic cells in breast cancer: a systematic review. Cells, 13(12, article no. 1048), 1-14. DOI Scopus4 WoS1 Europe PMC2 |
| 2024 |
Costin, I. C., & Marcu, L. G. (2024). Evaluation of heart substructures as a function of dose and radiation-induced toxicities in left-sided breast cancer radiotherapy. European Journal of Cancer Care, 2024(1294250), 1-12. DOI Scopus5 WoS4 |
| 2024 |
Marcu, L. G. (2024). Circadian rhythm-based cancer therapy in randomised clinical trials. Expert Review of Anticancer Therapy, 24(1-2), 29-39. DOI Scopus8 WoS8 Europe PMC6 |
| 2024 |
Abbott, N. L., Chauvie, S., Marcu, L., DeJean, C., Melidis, C., Wientjes, R., . . . Hansen, C. R. (2024). The role of medical physics experts in clinical trials: a guideline from the European Federation of Organisations for Medical Physics. Physica Medica, 126(104821), 1-16. DOI |
| 2023 |
Byrne, B., Marcu, L., Mazzoni, L. N., Caruana, C. J., Barry, A., Martin, G. M., . . . Gilligan, P. (2023). EFOMP Malaga Declaration 2023: An updated vision on Medical Physics in Europe. Physica Medica-European Journal Of Medical Physics, 111(102620), 1-3. DOI |
| 2023 |
Ebert, A., Short, M., Pule, L., Marcu, L., & Buckely, E. (2023). Variations in patterns of care of rectal cancer patients in South Australia according to sociodemographic characteristics: a registry study. European Journal of Cancer Care, 2023(7974059), 1-7. DOI |
| 2023 |
Caruana, C. J., Amos, R. A., Burgos, D., Heukelom, S., Jeremic, M. Z., Julkunen, P., . . . Pesznyak, C. (2023). EFOMP policy statement 18: medical physics education for the non-physics healthcare professions. Physica Medica, 111(102602), 1-4. DOI |
| 2023 |
Marcu, L. G., Moghaddasi, L., & Bezak, E. (2023). Cannot target what cannot be seen: molecular imaging of cancer stem cells. International Journal of Molecular Sciences, 24(2, article no. 1524), 1-17. DOI Scopus7 WoS6 Europe PMC6 |
| 2023 |
Bezak, E., Borrás, C., Hasford, F., Karmaker, N., Keyser, A., Stoeva, M., . . . Marcu, L. G. (2023). Science diplomacy in medical physics - an international perspective. Health and Technology, 13(3), 495-503. DOI Scopus6 WoS5 Europe PMC5 |
| 2023 |
Marcu, L. G., Dell'Oro, M., & Bezak, E. (2023). Opportunities in cancer therapies: deciphering the role of cancer stem cells in tumour repopulation. International Journal of Molecular Sciences, 24(24), 1-16. DOI Scopus3 WoS4 Europe PMC3 |
| 2023 |
Gazsi, I., & Marcu, L. G. (2023). Dosimetric evaluation of the benefits of intensity modulated techniques in cervical cancer radiotherapy. Romanian Journal of Physics, 68(7-8), 1-13. Scopus2 WoS2 |
| 2023 |
Buciuman, N., & Marcu, L. G. (2023). Dosimetric and clinical aspects of head and neck cancer reirradiation with intensity modulated radiotherapy techniques over the last decade. Physica Medica-European Journal Of Medical Physics, 112(102650), 1-9. DOI Scopus1 WoS1 |
| 2023 |
Ghemis, D. M., Marcu, L. G., Virag, V., & Virag, A. (2023). Dosimetric characteristics of 6MV flattening filter free and flattened beams among beam-matched linacs: a three-institutional study. Radiation Oncology, 18(1, article no. 126), 1-11. DOI Scopus6 WoS6 Europe PMC3 |
| 2023 |
Marcu, D. C., Grava, C., & Marcu, L. G. (2023). Current role of delta radiomics in head and neck oncology. International Journal of Molecular Sciences, 24(3), 1-11. DOI Scopus19 WoS17 Europe PMC18 |
| 2023 |
Ghemiș, D. M., & Marcu, L. G. (2023). Dosimetric parameters in hypofractionated stereotactic radiotherapy for brain metastases: do flattening filter-free beams bring benefits? A preliminary study. Cancers, 15(3), 1-12. DOI Scopus1 WoS1 Europe PMC1 |
| 2022 |
Irazola, L., Marcu, L. G., & Koutsouveli, E. (2022). Early career medical physicists' section at the 4th European Congress of Medical Physics. Physica medica, 103, 74-75. DOI Scopus3 WoS3 Europe PMC2 |
| 2022 |
Marcu, L. G. (2022). Developments on tumour site-specific chrono-oncology towards personalised treatment. Critical Reviews in Oncology / Hematology, 179(103803), 1-10. DOI Scopus4 WoS4 Europe PMC3 |
| 2022 |
Costin, I. C., & Marcu, L. G. (2022). Factors impacting on patient setup analysis and error management during breast cancer radiotherapy. Critical Reviews in Oncology/Hematology, 178(103798), 1-13. DOI Scopus14 WoS15 Europe PMC10 |
| 2022 |
Marcu, L. G., Abbott, N. L., Appelt, A., Chauvie, S., Gasnier, A., Hansen, C. R., . . . O'Doherty, J. (2022). The role of medical physicists in clinical trials across Europe. Physica Medica, 100, 31-38. DOI Scopus2 WoS3 Europe PMC2 |
| 2022 |
Buciuman, N., & Marcu, L. G. (2022). Adaptive radiotherapy in head and neck cancer using volumetric modulated arc therapy. Journal of Personalized Medicine, 12(5), 1-13. DOI Scopus10 WoS11 Europe PMC8 |
| 2022 |
Buciuman, N., & Marcu, L. G. (2022). Is there a dosimetric advantage of volumetric modulated arc therapy over intensity modulated radiotherapy in head and neck cancer?. European Archives of Oto-Rhino-Laryngology, 279(11), 5311-5321. DOI Scopus5 WoS3 Europe PMC1 |
| 2022 |
Marcu, L. G., Caruana, C. J., Lopez Medina, A., Mazzoni, L. N., Polycarpou, I., Manetou, A., & Koutsouveli, E. (2022). Early career medical physicist groups in Europe: an EFOMP survey. Physica Medica, 95, 89-93. DOI Scopus9 WoS7 Europe PMC2 |
| 2022 |
Marcu, L. G. (2022). Gender and sex-related differences in normal tissue effects induced by platinum compounds. Pharmaceuticals, 15(2, article no. 255), 1-14. DOI Scopus22 WoS19 Europe PMC18 |
| 2022 |
Bezak, E., Carson Chahhoud, K. V., Marcu, L. G., Stoeva, M., Lhotska, L., Barabino, G. A., . . . Frize, M. (2022). The biggest challenges resulting from the COVID-19 pandemic on gender-related work from home in biomedical fields: world-wide qualitative survey analysis. International Journal of Environmental Research and Public Health, 19(5), 1-16. DOI Scopus21 WoS17 Europe PMC10 |
| 2022 |
Moghaddasi, L., Reid, P., Bezak, E., & Marcu, L. G. (2022). Radiobiological and treatment-related aspects of spatially fractionated radiotherapy. International Journal of Molecular Sciences, 23(6, article no. 3366), 1-21. DOI Scopus42 WoS40 Europe PMC30 |
| 2022 |
Frize, M., Tsapaki, V., Lhotska, L., da Silva, A. M. M., Ibrahim, F., Bezak, E., . . . Marcu, L. G. (2022). Women in medical physics and biomedical engineering: past, present and future. Health and Technology, 12(3), 655-662. DOI Scopus3 WoS2 Europe PMC2 |
| 2022 |
Marcu, L. G., Bezak, E., & Sykes, P. J. (2022). Radiation research journals need to stipulate minimal dosimetry requirements for publishing research using x-radiation exposures. Radiation Research, 198(2), 204-206. DOI Scopus5 WoS5 Europe PMC5 |
| 2021 |
Marcu, L. G., Bezak, E., Peukert, D. D., & Wilson, P. (2021). Translational Research in FLASH Radiotherapy—From Radiobiological Mechanisms to In Vivo Results. Biomedicines, 9(2), 1-15. DOI Scopus35 WoS29 Europe PMC23 |
| 2021 |
Marcu, L. G., Chau, M., & Bezak, E. (2021). How much is too much? Systematic review of cumulative doses from radiological imaging and the risk of cancer in children and young adults.. Critical reviews in oncology/hematology, 160(103292), 103292. DOI Scopus27 WoS25 Europe PMC22 |
| 2021 |
Frize, M., Lhotska, L., Marcu, L. G., Stoeva, M., Barabino, G., Ibrahim, F., . . . Bezak, E. (2021). The impact of COVID-19 pandemic on gender-related work from home in STEM fields-Report of the WiMPBME Task Group. Gender, Work and Organization, 28(S2), 378-396. DOI Scopus31 WoS25 Europe PMC15 |
| 2021 |
Li, Y., Marcu, L. G., Hull, A., & Bezak, E. (2021). Radioimmunotherapy of glioblastoma multiforme - Current status and future prospects. Critical Reviews in Oncology/Hematology, 163(103395), 1-18. DOI Scopus18 WoS14 Europe PMC13 |
| 2021 |
Reid, P., Staudacher, A. H., Marcu, L. G., Olver, I., Moghaddasi, L., Brown, M. P., & Bezak, E. (2021). Characteristic differences in radiation-induced DNA damage response in human papillomavirus-negative and human papillomavirus-positive head and neck cancers with accumulation of fractional radiation dose. Head and Neck, 43(10), 3086-3096. DOI Scopus1 WoS1 Europe PMC1 |
| 2021 |
Marcu, L. G., & Marcu, D. C. (2021). Current omics trends in personalised head and neck cancer chemoradiotherapy. Journal of Personalized Medicine, 11(11, article no. 1094), 1-13. DOI Scopus11 WoS10 Europe PMC12 |
| 2021 |
Buciuman, N., & Marcu, L. G. (2021). Dosimetric justification for the use of volumetric modulated arc therapy in head and neck cancer—a systematic review of the literature. Laryngoscope Investigative Otolaryngology, 6(5), 999-1007. DOI Scopus20 WoS17 Europe PMC13 |
| 2021 |
Ghemiş, D. M., & Marcu, L. G. (2021). Progress and prospects of flattening filter free beam technology in radiosurgery and stereotactic body radiotherapy. Critical Reviews in Oncology/Hematology, 163(103396), 1-10. DOI Scopus13 WoS14 Europe PMC8 |
| 2021 |
Casares Magaz, O., Marcu, L. G., Prezado, Y., Koutsouveli, E., & Brambilla, M. (2021). EFOMP survey results on national radiotherapy dosimetry audits. Physica Medica, 84, 10-14. DOI Scopus7 WoS7 Europe PMC4 |
| 2021 |
Bodale, M., & Marcu, L. G. (2021). 140 years of medical physics in Romania. Physica Medica, 82, 46-53. DOI |
| 2021 |
Marcu, L. G., & Marcu, D. (2021). Points of view on artificial intelligence in medical imaging-one good, one bad, one fuzzy. Health and Technology, 11(1), 17-22. DOI Scopus13 WoS10 |
| 2021 |
Marcu, L. (2021). COVID-19 vaccination rates of medical physicists throughout Europe. Physica Medica, 28, 341-342. DOI |
| 2020 |
Marcu, L. G. (2020). The ever-changing role of medical physicists in the era of personalized medicine. Journal of Medical Physics, 45(4), 197-198. DOI Scopus3 Europe PMC4 |
| 2020 |
Dinu, A., Flonta, T., & Marcu, L. G. (2020). The impact of breast irradiation using thermoplastic mask on treatment delivery and acute effects. Romanian Reports in Physics, 72(2, article no. 603), 1-11. |
| 2020 |
Marcu, L. G. (2020). Imaging biomarkers of tumour proliferation and invasion for personalised lung cancer therapy. Journal of Personalized Medicine, 10(4), 1-17. DOI Scopus10 WoS8 Europe PMC6 |
| 2020 |
Marcu, L. G. (2020). Cancer stem cells as therapeutic targets of pancreatic cancer. Fundamental and Clinical Pharmacology, 34(2), 202-212. DOI Scopus8 WoS6 Europe PMC6 |
| 2020 |
Al Darwish, R., Marcu, L., & Bezak, E. (2020). Overview of current applications of the Timepix detector in spectroscopy, radiation and medical physics. Applied Spectroscopy Reviews, 55(3), 243-261. DOI Scopus6 WoS7 |
| 2020 |
De Courcy, L., Bezak, E., & Marcu, L. G. (2020). Gender-dependent radiotherapy: The next step in personalised medicine?. Critical Reviews in Oncology/Hematology, 147(102881), 102881-1-102881-8. DOI Scopus60 WoS55 Europe PMC45 |
| 2020 |
Reid, P., Staudacher, A. H., Marcu, L. G., Olver, I., Moghaddasi, L., Brown, M. P., & Bezak, E. (2020). Influence of the human papillomavirus on the radio-responsiveness of cancer stem cells in head and neck cancers. Scientific Reports, 10(1), 1-8. DOI Scopus12 WoS13 Europe PMC10 |
| 2020 |
Wong, H. Y., Marcu, L. G., Bezak, E., & Parange, N. A. (2020). Review of health economics of point-of-care testing worldwide and its efficacy of implementation in the primary health care setting in remote Australia. Risk Management and Healthcare Policy, 13, 379-386. DOI Scopus15 WoS12 Europe PMC13 |
| 2020 |
Reid, P., Staudacher, A. H., Marcu, L. G., Olver, I., Moghaddasi, L., Brown, M. P., . . . Bezak, E. (2020). Intrinsic Radiosensitivity Is Not the Determining Factor in Treatment Response Differences between HPV Negative and HPV Positive Head and Neck Cancers.. Cells, 9(8), 1-14. DOI Scopus7 WoS7 Europe PMC6 |
| 2019 |
Marcu, L. G., Boyd, C., & Bezak, E. (2019). Feeding the data monster: data science in head and neck cancer for personalized therapy. Journal of the American college of radiology, 16(12), 1695-1701. DOI Scopus9 WoS6 Europe PMC2 |
| 2019 |
Marcu, L., Boyd, C., & Bezak, E. (2019). Current issues regarding artificial intelligence in cancer and health care. Implications for medical physicists and biomedical engineers. Health and Technology, 9(4), 375-381. DOI Scopus12 WoS11 |
| 2019 |
Forster, J. C., Marcu, L. G., & Bezak, E. (2019). Approaches to combat hypoxia in cancer therapy and the potential for in silico models in their evaluation. Physica Medica, 64, 145-156. DOI Scopus23 WoS21 Europe PMC14 |
| 2019 |
Marcu, L. G., Forster, J. C., & Bezak, E. (2019). The Potential Role of Radiomics and Radiogenomics in Patient Stratification by Tumor Hypoxia Status. Journal of the American College of Radiology, 16(9), 1329-1337. DOI Scopus14 WoS14 Europe PMC10 |
| 2019 |
Huynh, M., Marcu, L. G., Giles, E., Short, M., Matthews, D., & Bezak, E. (2019). Are further studies needed to justify the use of proton therapy for paediatric cancers of the central nervous system? A review of current evidence. Radiotherapy and Oncology, 133, 140-148. DOI Scopus16 WoS15 Europe PMC12 |
| 2019 |
Reid, P., Marcu, L. G., Olver, I., Moghaddasi, L., Staudacher, A. H., & Bezak, E. (2019). Diversity of cancer stem cells in head and neck carcinomas: The role of HPV in cancer stem cell heterogeneity, plasticity and treatment response. Radiotherapy and Oncology, 135, 1-12. DOI Scopus33 WoS30 Europe PMC25 |
| 2019 |
Barabino, G., Frize, M., Ibrahim, F., Kaldoudi, E., Lhotska, L., Marcu, L., . . . Bezak, E. (2019). Solutions to Gender Balance in STEM Fields Through Support, Training, Education and Mentoring: Report of the International Women in Medical Physics and Biomedical Engineering Task Group. Science and Engineering Ethics, 26(1), 275-292. DOI Scopus28 WoS26 Europe PMC12 |
| 2019 |
Marcu, L. G., & Marcu, D. (2019). The role of hypofractionated radiotherapy in the management of head and neck cancer - a modelling approach. Journal of theoretical biology, 482(article no. 109998), 1-9. DOI Scopus7 WoS6 Europe PMC5 |
| 2018 |
Morias, S., Marcu, L., Short, M., Giles, E., & Bezak, E. (2018). Do SABR-related toxicities for lung cancer depend on treatment delivery?. Critical Reviews in Oncology/Hematology, 129, 67-78. DOI Scopus1 WoS1 Europe PMC1 |
| 2018 |
Marcu, L., Reid, P., & Bezak, E. (2018). The promise of novel biomarkers for head and neck cancer from an imaging perspective. International Journal of Molecular Sciences, 19(9), 15 pages. DOI Scopus21 WoS20 Europe PMC18 |
| 2018 |
Huynh, M., Marcu, L. G., Giles, E., Short, M., Matthews, D., & Bezak, E. (2018). Current status of proton therapy outcome for paediatric cancers of the central nervous system – Analysis of the published literature. Cancer Treatment Reviews, 70, 272-288. DOI Scopus20 WoS16 Europe PMC11 |
| 2018 |
Morias, S., Marcu, L. G., Short, M., Giles, E., Potter, A., Shepherd, J., . . . Bezak, E. (2018). Treatment-Related Adverse Effects in Lung Cancer Patients after Stereotactic Ablative Radiation Therapy. Journal of Oncology, 2018(6483626), 16 pages. DOI Scopus19 WoS16 Europe PMC11 |
| 2018 |
Marcu, L., Bezak, E., & Allen, B. (2018). Global comparison of targeted alpha vs targeted beta therapy for cancer: in vitro, in vivo and clinical trials. Critical Reviews in Oncology/Hematology, 123, 7-20. DOI Scopus121 WoS101 Europe PMC76 |
| 2018 |
Reid, P., Wilson, P., Li, Y., Marcu, L., Staudacher, A., Brown, M., & Bezak, E. (2018). Experimental investigation of radiobiology in head and neck cancer cell lines as a function of HPV status, by MTT assay. Scientific Reports, 8(1), 7 pages. DOI Scopus10 WoS9 Europe PMC5 |
| 2018 |
Marcu, L., Moghaddasi, L., & Bezak, E. (2018). Imaging of tumor characteristics and molecular pathways with PET: developments over the last decade toward personalized cancer therapy. International Journal of Radiation Oncology: Biology, Physics, 102(4), 1165-1182. DOI Scopus36 WoS33 Europe PMC25 |
| 2017 |
Marcu, L. G. (2017). Photons - Radiobiological issues related to the risk of second malignancies. Physica Medica, 42, 1-8. DOI Scopus25 WoS22 Europe PMC17 |
| 2017 |
Bezak, E., Takam, R., Yeoh, E., & Marcu, L. (2017). The risk of second primary cancers due to peripheral photon and neutron doses received during prostate cancer external beam radiation therapy. Physica Medica, 42, 253-258. DOI Scopus19 WoS15 Europe PMC13 |
| 2017 |
So, B., Marcu, L. G., Olver, I., Gowda, R., & Bezak, E. (2017). Cocktail without hangover: in search for the optimal chemotherapy in the combined management of non-operable esophageal carcinomas. Acta Oncologica, 56(7), 899-908. DOI Scopus3 WoS3 Europe PMC2 |
| 2017 |
Marcu, L. G., & Marcu, D. (2017). The effect of targeted therapy on recruited cancer stem cells in a head and neck carcinoma model. Cell proliferation, 50(6, article no. e12380), 1-9. DOI Scopus4 WoS5 Europe PMC4 |
| 2017 |
Reid, P., Wilson, P., Li, Y., Marcu, L. G., Staudacher, A. H., Brown, M. P., & Bezak, E. (2017). In vitro investigation of head and neck cancer stem cell proportions and their changes following X-ray irradiation as a function of HPV status. PLoS ONE, 12(10), 16 pages. DOI Scopus20 WoS18 Europe PMC17 |
| 2016 |
Chirla, R., & Marcu, L. G. (2016). PET-based quantification of statistical properties of hypoxic tumor subvolumes in head and neck cancer. Physica Medica, 32(1), 23-35. DOI Scopus20 WoS21 Europe PMC17 |
| 2016 |
Marcu, L., Marcu, D., & Filip, S. (2016). In silico study of the impact of cancer stem cell dynamics and radiobiological hypoxia on tumour response to hyperfractionated radiotherapy. Cell Proliferation, 49(3), 304-314. DOI Scopus13 WoS12 Europe PMC8 |
| 2016 |
Marcu, L. G. (2016). Future treatment directions for HPV-associated head and neck cancer based on radiobiological rationale and current clinical evidence. Critical Reviews in Oncology/Hematology, 103, 27-36. DOI Scopus21 WoS19 Europe PMC17 |
| 2016 |
Santos, A., Marcu, L., Wong, C., & Bezak, E. (2016). Risk estimation of second primary cancers after breast radiotherapy. Acta Oncologica, 55(11), 1331-1337. DOI Scopus30 WoS25 Europe PMC21 |
| 2016 |
Marcu, L. G., & Marcu, D. (2016). In silico modelling of a cancer stem cell-targeting agent and its effects on tumour control during radiotherapy. Scientific reports, 6(1), 1-8. DOI Scopus17 WoS14 Europe PMC9 |
| 2015 |
Bezak, E., Takam, R., & Marcu, L. (2015). Peripheral photon and neutron doses from prostate cancer external beam irradiation. Radiation Protection Dosimetry, 167(4), 591-601. DOI Scopus11 WoS7 Europe PMC2 |
| 2015 |
Jennings, M., Marcu, L., & Bezak, E. (2015). PET-specific parameters and radiotracers in theoretical tumour modelling. Computational and Mathematical Methods in Medicine, 2015(415923), 415923-1-415923-11. DOI Scopus10 WoS10 Europe PMC8 |
| 2015 |
Marcu, L. G., Bezak, E., Toma-Dasu, I., & Dasu, A. (2015). Predictive models of tumour response to treatment using functional imaging techniques. Computational and Mathematical Methods in Medicine, 2015, 571371-1-571371-2. DOI Scopus2 WoS1 Europe PMC2 |
| 2015 |
Marcu, L. G. (2015). The first Rs of radiotherapy: or standing on the shoulders of giants. Australasian physical and engineering sciences in medicine, 38(4), 531-541. DOI Scopus4 WoS3 Europe PMC3 |
| 2014 |
Marcu, L., Santos, A., & Bezak, E. (2014). Risk of second primary cancer after breast cancer treatment. European Journal of Cancer Care, 23(1), 51-64. DOI Scopus33 WoS32 Europe PMC25 |
| 2014 |
Marcu, L., Harriss-Phillips, W., & Filip, S. (2014). Hypoxia in head and neck cancer in theory and practice: a PET-based imaging approach. Computational and Mathematical Methods in Medicine, 2014, 624642-1-624642-13. DOI Scopus7 WoS7 Europe PMC7 |
| 2014 |
Marcu, L. (2014). Tumour repopulation and the role of abortive division in squamous cell carcinomas during chemotherapy. Cell Proliferation, 47(4), 318-325. DOI Scopus8 WoS8 Europe PMC8 |
| 2013 |
Marcu, L. (2013). Improving therapeutic ratio In head and neck cancer with adjuvant and cisplatin-based treatments. BioMed Research International, 2013, 1-9. DOI Scopus10 WoS8 Europe PMC6 |
| 2013 |
Rutten, T., Lawson, J., & Marcu, L. (2013). Treatment technique evolution and dosimetry trends over seven years of low dose rate prostate brachytherapy at an Australian institution. Physica Medica, 29(6), 662-669. DOI Scopus6 WoS6 Europe PMC5 |
| 2013 |
Marcu, L., & Lawson, J. (2013). Technical and dosimetric aspects of iodine-125 seed reimplantation in suboptimal prostate implants. British Journal of Radiology, 86(1026), 130058-1-130058-10. DOI Scopus4 WoS3 Europe PMC2 |
| 2013 |
Marcu, L., & Gowda, R. (2013). Comparison of 3 different postimplant dosimetry methods following permanent ¹²⁵I prostate seed brachytherapy. Medical Dosimetry, 38(3), 309-314. DOI Scopus7 WoS7 Europe PMC5 |
| 2013 |
Allen, B., Bezak, E., & Marcu, L. (2013). Quo vadis radiotherapy? Technological advances and the rising problems in cancer management. BioMed Research International, 2013(749203), 1-9. DOI Scopus11 WoS9 Europe PMC9 |
| 2012 |
Moorrees, J., Lawson, J., & Marcu, L. (2012). Assessment of I-125 seed implant accuracy when using the live-planning technique for low dose rate prostate brachytherapy. Radiation Oncology, 7(196), 1-9. DOI Scopus3 WoS3 Europe PMC1 |
| 2012 |
Moghaddasi, F., Bezak, E., & Marcu, L. (2012). Current challenges in clinical target volume definition: tumour margins and microscopic extensions. Acta Oncologica, 51(8), 984-995. DOI Scopus24 WoS22 Europe PMC21 |
| 2012 |
Marcu, L., & Bezak, E. (2012). Influence of stem-cell cycle time on accelerated re-population during radiotherapy in head and neck cancer. Cell Proliferation, 45(5), 404-412. DOI Scopus5 WoS5 Europe PMC5 |
| 2012 |
Marcu, L., & Harriss-Phillips, W. (2012). In silico modelling of treatment-induced tumour cell kill: Developments and advances. Computational and Mathematical Methods in Medicine, 2012, 1-16. DOI Scopus23 WoS20 Europe PMC17 |
| 2012 |
Moghaddasi, F., Bezak, E., & Marcu, L. (2012). In silico modelling of tumour margin diffusion and infiltration: Review of current status. Computational and Mathematical Methods in Medicine, 2012(672895), 1-12. DOI Scopus10 WoS8 Europe PMC7 |
| 2012 |
Penfold, S., Marcu, L., Lawson, J., & Asp, J. (2012). Evaluation of physician eye lens doses during permanent seed implant brachytherapy for prostate cancer. Journal of Radiological Protection, 32(3), 339-347. DOI Scopus3 WoS3 Europe PMC1 |
| 2012 |
Marcu, L., Lawson, J., Rutten, T., & Gowda, R. (2012). Quality indicators and technique for analyzing permanent I-125 prostate seed implants: Seven years postimplant dosimetry evaluation. Medical Physics, 39(7), 4123-4131. DOI Scopus7 WoS6 Europe PMC6 |
| 2012 |
Takam, R., Bezak, E., Liu, G., & Marcu, L. (2012). The use of enriched ⁶Li and ⁷Li Lif:Mg,Cu,P glass-rod thermoluminescent dosemeters for linear accelerator out-of-field radiation dose measurements. Radiation Protection Dosimetry, 150(1), 22-33. DOI Scopus10 WoS11 Europe PMC2 |
| 2012 |
Marcu, L., Bezak, E., & Filip, S. (2012). The role of PET imaging in overcoming radiobiological challenges in the treatment of advanced head and neck cancer. Cancer Treatment Reviews, 38(3), 185-193. DOI Scopus6 WoS5 Europe PMC4 |
| 2012 |
Marcu, L., & Bezak, E. (2012). Neoadjuvant cisplatin for head and neck cancer: Simulation of a novel schedule for improved therapeutic ratio. Journal of Theoretical Biology, 297, 41-47. DOI Scopus7 WoS6 Europe PMC4 |
| 2012 |
Bezak, E., Marcu, L., & Penfold, S. (2012). Computational and mathematical modeling of tumor kinetics and response to radiation and chemotherapy. Computational and Mathematical Methods in Medicine, 2012, 702675-1-702675-2. DOI |
| 2011 |
Takam, R., Bezak, E., Marcu, L., & Yeoh, E. (2011). Out-of-field neutron and leakage photon exposures and the associated risk of second cancers in high-energy photon radiotherapy: Current status. Radiation Research, 176(4), 508-520. DOI Scopus46 WoS45 Europe PMC30 |
| 2010 |
Marcu, L., & Yeoh, E. (2010). The emerging role of predictive assays in the management of head and neck cancer. Austral-Asian Journal of Cancer, 9(2), 71-77. |
| 2010 |
Marcu, L., & Bezak, E. (2010). Modelling of tumour repopulation after chemotherapy. Australasian Physical and Engineering Sciences in Medicine, 33(3), 265-270. DOI Scopus12 WoS12 Europe PMC12 |
| 2010 |
Takam, R., Bezak, E., Yeoh, E., & Marcu, L. (2010). Assessment of normal tissue complications following prostate cancer irradiation: Comparison of radiation treatment modalities using NTCP models. Medical Physics, 37(9), 5126-5137. DOI Scopus26 WoS25 Europe PMC20 |
| 2010 |
Marcu, L., & Bezak, E. (2010). Stochastic modelling of the role of cisplatin in altered fractionation schedules for head and neck cancer. Physica Medica, 26(4), 177-183. DOI Scopus4 WoS3 Europe PMC4 |
| 2010 |
Marcu, L. (2010). Altered fractionation in radiotherapy: From radiobiological rationale to therapeutic gain. Cancer Treatment Reviews, 36(8), 606-614. DOI Scopus37 WoS32 Europe PMC29 |
| 2009 |
Marcu, L., & Bezak, E. (2009). Radiobiological modeling of interplay between accelerated repopulation and altered fractionation schedules in head and neck cancer. Journal of Medical Physics, 34(4), 206-211. DOI Scopus17 WoS16 Europe PMC12 |
| 2009 |
Marcu, L., & Yeoh, E. (2009). A review of risk factors and genetic alterations in head and neck carcinogenesis and implications for current and future approaches to treatment. Journal of Cancer Research and Clinical Oncology, 135(10), 1303-1314. DOI Scopus61 WoS57 Europe PMC48 |
| 2009 |
Marcu, L. (2009). The role of amifostine in the treatment of head and neck cancer with cisplatin-radiotherapy. European Journal of Cancer Care, 18(2), 116-123. DOI Scopus13 WoS13 Europe PMC10 |
| 2008 |
Harriss-Phillips, W., Bezak, E., Yeoh, E., & Marcu, L. (2008). Efficient Monte Carlo modelling of individual tumour cell propagation for hypoxic head and neck cancer. Physics in Medicine and Biology, 53(17), 4489-4507. DOI Scopus17 WoS16 Europe PMC11 |
| 2006 |
Marcu, L., Bezak, E., & Olver, I. (2006). Scheduling cisplatin and radiotherapy in the treatment of squamous cell carcinomas of the head and neck: a modelling approach. Physics in Medicine and Biology, 51(15), 3625-3639. DOI Scopus30 WoS27 Europe PMC25 |
| 2006 |
Marcu, L., & Olver, I. (2006). Tirapazamine: from bench to clinical trials. Current Clinical Pharmacology, 1(1), 71-79. DOI Scopus105 WoS102 Europe PMC77 |
| 2006 |
Marcu, L., & Quach, K. (2006). The role of post-implant dosimetry in the quality assessment of prostate implants. The RAH experience. Australasian Physical and Engineering Sciences in Medicine, 29(4), 310-314. DOI |
| 2005 |
Marcu, L., Bezak, E., Olver, I., & Van Doorn, T. (2005). Tumour resistance to cisplatin: a modelling approach. Physics in Medicine and Biology, 50(1), 93-102. DOI Scopus21 WoS20 Europe PMC15 |
| 2004 |
Marcu, L., Van Doorn, T., & Olver, I. (2004). Modelling of post-irradiation accelerated repopulation in squamous cell carcinomas. Physics in Medicine and Biology, 49(16), 3767-3779. DOI Scopus36 WoS34 Europe PMC31 |
| 2004 |
Marcu, L., Lyons, A., Bezak, E., & Van Doorn, T. (2004). The onset of tumour repopulation after radiotherapy in theoretical and in vitro models. Austral-Asian Journal of Cancer, 3(3), 167-171. |
| 2003 |
Marcu, L., Van Doorn, T., & Olver, I. (2003). Cisplatin and radiotherapy in the treatment of locally advanced head and neck cancer - a review of their cooperation. Acta Oncologica, 42(4), 315-325. DOI Scopus60 WoS53 Europe PMC47 |